Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 2
Submit an article Journal homepage
86
Views
29
CrossRef citations to date
0
Altmetric
Original

Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL)

Dr Tryfonia Mainou-Fowler Academic Haematology, School of Clinical and Laboratory Sciences, Newcastle upon Tyne, UKCorrespondence[email protected]
,
Brian Angus Histopathology
,
Susan Miller Academic Haematology, School of Clinical and Laboratory Sciences, Newcastle upon Tyne, UK
,
Stephen J. Proctor Academic Haematology, School of Clinical and Laboratory Sciences, Newcastle upon Tyne, UK
,
Penelope R. A. Taylor Hematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
&
Katrina M. Wood Histopathology
Pages 223-230 | Received 11 Aug 2005, Published online: 01 Jul 2009

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Antonio Rueda, David Olmos, Luis Vicioso, Cristina Quero, Elena Gallego, Bella Isabel Pajares-Hachero, Marta Mendiola, María Casanova, Martina Álvarez, Mariano Provencio & Emilio Alba. (2015) Role of vascular endothelial growth factor C in classical Hodgkin lymphoma. Leukemia & Lymphoma 56:5, pages 1286-1294.
Read now
Georgios S. Dimtsas, Eleni C. Georgiadi, Petros Karakitsos, Theodoros P. Vassilakopoulos, Irene Thymara, Penelope Korkolopoulou, Efstratios Patsouris, Christos Kittas & Ipatia A. Doussis-Anagnostopoulou. (2014) Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma. Leukemia & Lymphoma 55:3, pages 558-564.
Read now
Heiner Adams, Ellen C Obermann, Stephan Dirnhofer & Alexandar Tzankov. (2011) Targetable molecular pathways in classical Hodgkin's lymphoma. Expert Opinion on Investigational Drugs 20:2, pages 141-151.
Read now
Myriam Weyl Ben Arush, I. Shafat, Ayelet Ben Barak, Rachel Bar Shalom, Eugene Vlodavsky & Neta Ilan. (2009) PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study. Pediatric Hematology and Oncology 26:4, pages 157-164.
Read now
M. Weyl Ben Arush, A. Ben Barak, S. Maurice & E. Livne. (2007) SERUM VEGF AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN HODGKIN LYMPHOMA. Pediatric Hematology and Oncology 24:2, pages 111-115.
Read now

Articles from other publishers (24)

Srushti Mahajan, Mayur Aalhate, Santosh Kumar Guru & Pankaj Kumar Singh. (2022) Nanomedicine as a magic bullet for combating lymphoma. Journal of Controlled Release 347, pages 211-236.
Crossref
Lauren Shea, Marcus P. Watkins, Fei Wan, Amanda F. Cashen, Nina D. Wagner-Johnston, Meagan A. Jacoby, Camille N. Abboud, John F. Dipersio, David D. Hurd, Samantha M. Jaglowski, Nancy L. Bartlett & Todd A. Fehniger. (2020) A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation 26:12, pages 2223-2228.
Crossref
Andrei Turbatu, Andrei Coliţă, Marilena Stoian, Ana-Maria Bordea, Mădălina Oprea, Cecilia Ghimici, Ionel Gelatu, Loredana Alina Ghimfus, Andra Georgiana Stoica, Cristina Elena Banu & Anca-Roxana Lupu. (2019) How Epstein-Barr Virus “Manipulates” The Tumoral Microenvironment in Hodgkin Lymphoma?. Internal Medicine 16:2, pages 47-52.
Crossref
Young Wha Koh, Jae‐Ho Han, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2017) Epstein‐Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma. Hematological Oncology 36:1, pages 182-188.
Crossref
Paul Murray & Maha Ibrahim. 2018. Precision Molecular Pathology of Hodgkin Lymphoma. Precision Molecular Pathology of Hodgkin Lymphoma 91 109 .
Amany A. Bary. (2017) Differential vascular endothelial growth factor expression in neoplastic and non-neoplastic components of classic Hodgkin’s lymphoma. Egyptian Journal of Pathology 37:1, pages 36-41.
Crossref
Hriday Bera & Sridevi Chigurupati. (2016) Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer. European Journal of Medicinal Chemistry 124, pages 992-1003.
Crossref
Rajendra Gharbaran. (2016) Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs—syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin’s lymphoma. Tumor Biology 37:9, pages 11573-11588.
Crossref
Thomas Schirrmann, Miriam Steinwand, Xenia Wezler, Andre ten Haaf, Mehmet K. Tur & Stefan Barth. (2013) CD30 as a Therapeutic Target for Lymphoma. BioDrugs 28:2, pages 181-209.
Crossref
Young Wha Koh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2014) CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma. PLoS ONE 9:1, pages e87066.
Crossref
Carla Minoia, Carmela Quero, Mariaconsilia Asselti, Ida Galise, Alessia L. Marzano, Angela Iacobazzi, Antonio Rana, Francesca Merchionne, Simona Serratì, Giacoma De Tullio, Giovanni Quintana, Michela Casiello, Eugenio Maiorano, Giovanni Simone, Francesco A. Zito, Pasquale Iacopino & Attilio Guarini. (2013) Changes in angiogenesis and hypoxia‐inducible factor‐1α protein expression in relapsed/refractory indolent non‐ H odgkin lymphomas . British Journal of Haematology 163:5, pages 640-645.
Crossref
Young Wha Koh, Chansik Park, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2013) Prognostic Significance of COX-2 Expression and Correlation With Bcl-2 and VEGF Expression, Microvessel Density, and Clinical Variables in Classical Hodgkin Lymphoma. American Journal of Surgical Pathology 37:8, pages 1242-1251.
Crossref
Julian Paesler, Iris Gehrke, Simon Jonas Poll‐Wolbeck & Karl‐Anton Kreuzer. (2012) Targeting the vascular endothelial growth factor in hematologic malignancies. European Journal of Haematology 89:5, pages 373-384.
Crossref
Francis Kar-ho Lee, Ann Dorothy King, Brigitte Buig-Yue Ma & David Ka-wai Yeung. (2012) Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers. European Journal of Radiology 81:4, pages 784-788.
Crossref
Fatma Visal Okur, Ceyda Karadeniz, Munevver Buyukpamukcu, Aynur Oguz, Aysegul Yucel, Peyami Cinaz, Suna Emir & Ali Varan. (2010) Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma. Pediatric Blood & Cancer 55:7, pages 1272-1277.
Crossref
P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon & R. P. Phipps. (2010) Anticancer Role of PPAR Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes . PPAR Research 2010, pages 1-36.
Crossref
Michael Medinger, Natalie Fischer & Alexandar Tzankov. (2010) Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies. Journal of Oncology 2010, pages 1-13.
Crossref
Annelies Bronckaers, Federico Gago, Jan Balzarini & Sandra Liekens. (2009) The dual role of thymidine phosphorylase in cancer development and chemotherapy. Medicinal Research Reviews 29:6, pages 903-953.
Crossref
Freda H. Passam, Michael G. Alexandrakis, Maria Kafousi, Marianthi Fotinou, Katerina Darivianaki, George Tsirakis, Paraskevi A. Roussou, Efstathios N. Stathopoulos & Nikolaos M. Siafakas. (2009) Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma. Pathology - Research and Practice 205:1, pages 11-20.
Crossref
Elvan Caglar Citak, Aynur Oguz, Ceyda Karadeniz & Nalan Akyurek. (2008) Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma. Pathology - Research and Practice 204:2, pages 89-96.
Crossref
Elena Riboldi, Silvano Sozzani & Marco Presta. 2008. Angiogenesis in Inflammation: Mechanisms and Clinical Correlates. Angiogenesis in Inflammation: Mechanisms and Clinical Correlates 29 43 .
Gunilla Enblad, Daniel Molin, Ingrid Glimelius, Marie Fischer & Gunnar Nilsson. (2007) The Potential Role of Innate Immunity in the Pathogenesis of Hodgkin's Lymphoma. Hematology/Oncology Clinics of North America 21:5, pages 805-823.
Crossref
Antonio Rueda, David Olmos, Vicente Villareal, Esperanza Torres, Bella Isabel Pajares & Emilio Alba. (2007) Elevated Vascular Endothelial Growth Factor Pretreatment Levels Are Correlated with the Tumor Burden in Hodgkin Lymphoma and Continue to Be Elevated in Prolonged Complete Remission. Clinical Lymphoma and Myeloma 7:6, pages 400-405.
Crossref
Xunwei Dong, Zhong Chao Han & Renchi Yang. (2007) Angiogenesis and antiangiogenic therapy in hematologic malignancies. Critical Reviews in Oncology/Hematology 62:2, pages 105-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.